DrugPatentWatch Database Preview
Details for Patent: 6,652,880
Which drugs does patent 6,652,880 protect, and when does it expire?
Patent 6,652,880 protects TAYTULLA and is included in one NDA.
This patent has thirty-one patent family members in twenty-three countries.
Summary for Patent: 6,652,880
| Title: | Oral pharmaceutical compositions containing long-chain triglycerides and liphophilic surfactants |
| Abstract: | This invention is directed to pharmaceutical compositions for oral administration, wherein the drug or active ingredient is known to have stability problems associated with the use of free fatty acids. The compositions of the invention enhance the solubility of such compounds and improve the storage stability thereof and can be advantageously used in soft-gel and hard-shell capsular formulations. The liquid pharmaceutical compositions, according to the present invention, have a drug dissolved in a liquid vehicle. The liquid vehicle comprising a glyceride of a long chain fatty acid and a lypophilic surfactant having an HLB of less than ten. The composition, according to the invention, is also substantially free of free fatty acids. |
| Inventor(s): | Aylwin; Elizabeth Anne (Swindon, GB), Banbury; Susan (Cheltenham, GB), Ferdinando; Josephine Joan Christine (Tadley, GB), de Nijs; Henrik (Oss, NL) |
| Assignee: | R.P. Scherer Technologies, Inc. (Paradise Valley, NV) |
| Application Number: | 09/914,576 |
| Prior Art and Litigation Support | Order Prior Art and Litigation support for Patent 6,652,880 |
|
Patent Claim Types: see list of patent claims | Composition; Dosage form; |
Drugs Protected by US Patent 6,652,880
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Apil | TAYTULLA | ethinyl estradiol; norethindrone acetate | CAPSULE;ORAL | 204426-001 | Apr 19, 2013 | RX | Yes | Yes | ➤ Sign Up | ➤ Sign Up | Y | ➤ Sign Up | ||||
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
Foreign Priority and PCT Information for Patent: 6,652,880
| Foriegn Application Priority Data | ||
| Foreign Country | Foreign Patent Number | Foreign Patent Date |
| United Kingdom | 9907715 | Apr 01, 1999 |
| PCT Information | |||
| PCT Filed | March 29, 2000 | PCT Application Number: | PCT/US00/08426 |
| PCT Publication Date: | October 12, 2000 | PCT Publication Number: | WO00/59482 |
International Family Members for US Patent 6,652,880
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| Austria | 311177 | ➤ Sign Up | |||
| Australia | 4049400 | ➤ Sign Up | |||
| Australia | 763971 | ➤ Sign Up | |||
| Brazil | 0009373 | ➤ Sign Up | |||
| Brazil | PI0009373 | ➤ Sign Up | |||
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
